|
TIGD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.750000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.622600E-01 |
| Normal-vs-Stage2 |
1.499840E-01 |
| Normal-vs-Stage3 |
7.338200E-01 |
| Normal-vs-Stage4 |
8.741800E-01 |
| Stage1-vs-Stage2 |
2.917800E-01 |
| Stage1-vs-Stage3 |
4.883400E-01 |
| Stage1-vs-Stage4 |
4.706400E-01 |
| Stage2-vs-Stage3 |
1.733750E-01 |
| Stage2-vs-Stage4 |
1.828160E-01 |
| Stage3-vs-Stage4 |
8.616200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.350000E-01 |
| Normal-vs-AfricanAmerican |
3.797400E-01 |
| Normal-vs-Asian |
1.017380E-01 |
| Caucasian-vs-AfricanAmerican |
6.053600E-01 |
| Caucasian-vs-Asian |
1.579230E-01 |
| AfricanAmerican-vs-Asian |
6.491000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.630800E-01 |
| Normal-vs-Female |
3.428000E-01 |
| Male-vs-Female |
5.278600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.878800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.379600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.901600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.259600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.707200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.122400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.229600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.872800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.725000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.431600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.427200E-01 |
| Classical-VS-Follicular |
3.903400E-01 |
| Classical-VS-Other |
8.236400E-01 |
| Classical-VS-Normal |
1.782810E-01 |
| Tall-VS-Follicular |
5.632600E-01 |
| Tall-VS-Other |
7.052600E-01 |
| Tall-VS-Normal |
9.374800E-01 |
| Follicular-VS-Other |
9.517400E-01 |
| Follicular-VS-Normal |
6.107000E-01 |
| Other-VS-Normal |
7.404200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.443600E-01 |
| Normal-vs-N1 |
9.096600E-01 |
| N0-vs-N1 |
3.313200E-01 |
|
|
